Home › Metabolic › Tirzepatide (10mg)
Metabolic Research Peptide
Tirzepatide (10mg)
GLP-1/GIP dual agonist · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →About Tirzepatide
Tirzepatide is a dual agonist peptide acting on both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is studied in metabolic research for its combined effects on glucose handling, insulin sensitivity, and energy balance in laboratory and pre-clinical models.
Within the research community it is studied in laboratory and pre-clinical models. It is supplied by Vital Research Labs strictly as a reference compound for in-vitro laboratory investigation.
Molecular & physical profile
| Compound | Tirzepatide |
|---|---|
| Category | Metabolic |
| CAS Number | 2023788-19-2 |
| Form | Lyophilised Powder |
| Appearance | White to off-white solid |
| Purity | 99.691% (this batch) |
| Batch | CS-ze10-0202 |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values are recorded on the Certificate of Analysis supplied with the compound.
Reconstitution & handling
Tirzepatide is supplied as a lyophilised (freeze-dried) powder. For research handling it is typically reconstituted with bacteriostatic water; the exact volume depends on the concentration a given research protocol calls for. Our reconstitution calculator can be used to work out volumes for a target research concentration. Handle under appropriate laboratory conditions and avoid repeated freeze–thaw cycles of the reconstituted solution.
Storage & stability
- Lyophilised powder — -20 °C — protect from light & moisture.
- Reconstituted solution — 2–8 °C — use within 28 days.
- Handling — minimise freeze–thaw cycles; keep vials sealed until use.
Quality & testing
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory. Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS). This batch is verified at 99.691% purity, and a Certificate of Analysis is available for the batch so researchers can verify exactly what they are working with.
Shipping within Australia
Tirzepatide is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
Frequently asked questions
Is Tirzepatide (10mg) available in Australia for research?
Yes. Vital Research Labs supplies research-grade Tirzepatide (10mg) to Australian research customers, dispatched domestically. It is provided strictly for in-vitro laboratory research and is not for human or veterinary use.
What purity is your Tirzepatide (10mg)?
This batch is verified at 99.691% purity by third-party analytical testing (HPLC for purity, mass spectrometry for identity). A Certificate of Analysis is available for the batch.
How is Tirzepatide (10mg) tested?
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity. Batch-specific values are recorded on the Certificate of Analysis.
How should Tirzepatide (10mg) be stored?
The lyophilised powder is stored at -20 degrees C, protected from light and moisture. Once reconstituted for research it is kept at 2-8 degrees C and typically used within 28 days.
Is Tirzepatide (10mg) intended for human use?
No. Tirzepatide (10mg) supplied by Vital Research Labs is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.